Interaction Between Sclerostin and Mast Cells in Fibro‐Osseous Lesions of the Jaws
Oral Diseases · 2025
DOI: 10.1111/odi.15232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Riéli Elis Schulz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil. Hauptthemen laut MEDLINE: Mast Cells, Fibroma, Ossifying, Fibrous Dysplasia of Bone, Jaw Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina.
Abstract (Originalsprache)
Objective
To assess the sclerostin, β‐catenin, and tryptase expression in fibro‐osseous lesions (FOL) of the jaws. Subjects and Methods Immunohistochemistry analysis was performed for these proteins on FOL and non‐lesional bone. The sclerostin‐positive cells were scored from 0 (no expression) to 3 (high expression).
Results
We analyzed 46 FOL biopsies and selected 38 patients. Categorization showed 15 fibrous dysplasia (FD), eight juvenile trabecular ossifying fibroma (JTOF), two psammomatoid ossifying fibroma (PsOF), and 13 FOL. We found more sclerostin‐positive cells in fibrous tissue than in bone, showing a phenotype like mast cells with strong dot‐cytoplasmic positivity. The analysis of sclerostin‐positive cell lesions (scored as 2 and 3) showed also tryptase positivity in 80.9% of 21 biopsies. β‐catenin was diffusely expressed on the fibrous component, mostly with cytosol staining. Non‐lesional bone showed sclerostin expression in medullary spaces and a few osteocytes.
Conclusions
Sclerostin‐positive cells are mostly found in the fibrous tissue of FOL, and the tryptase mast cell marker was present in most of the lesions that were positive for sclerostin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
- School of Dentistry, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
- Presidente Tancredo de Almeida Neves Universitary Center - UNIPTAN, São João Del Rey, Minas Gerais, Brazil.
- Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.
- Department of Pathology, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
ORCID-Profile: Riéli Elis Schulz, Michel Calil Abrão-Neto, Thiago Pires Claudio, Vinícius Gonçalves de Souza, Elena Riet Correa Rivero, Rogério Oliveira Gondak, Gustavo Davi Rabelo
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
Zitieren
APA
Schulz, R. E., Abrão-Neto, M. C., Claudio, T. P., de Souza, V. G., Rivero, E. R. C., Gondak, R. O., & Rabelo, G. D. (2025). Interaction Between Sclerostin and Mast Cells in Fibro‐Osseous Lesions of the Jaws. Oral Diseases. https://doi.org/10.1111/odi.15232
Vancouver
Schulz RE, Abrão-Neto MC, Claudio TP, de Souza VG, Rivero ERC, Gondak RO, et al. Interaction Between Sclerostin and Mast Cells in Fibro‐Osseous Lesions of the Jaws. Oral Diseases. 2025. doi:10.1111/odi.15232
BibTeX
@article{Schulz2025,
author = {Schulz, Riéli Elis and Abrão-Neto, Michel Calil and Claudio, Thiago Pires and de Souza, Vinícius Gonçalves and Rivero, Elena Riet Correa and Gondak, Rogério Oliveira and Rabelo, Gustavo Davi},
title = {Interaction Between Sclerostin and Mast Cells in Fibro‐Osseous Lesions of the Jaws},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15232}
}
EUVIMED